World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
42647
World Ranking
7019
National Ranking
3688

Overview

W. Douglas Weaver is affiliated with Ford Motor Company in the United States. Their professional activities are based in the United States, where they contribute to the automotive industry through research and development.

There is no specific information available regarding the topics of their published research, co-authors they frequently collaborate with, or publication venues in which they have appeared. Similarly, details about scholarly papers, including titles, years of publication, and venues, are not provided.

No records indicate their involvement in book publications or details about the number or nature of any books published. The main and subfields of their scientific study have not been specified either, leaving a gap in understanding their academic focus or specialization.

No main topics associated with their research work have been identified, and there are no listed awards or honors that recognize their contributions. There is no information suggesting that Weaver is deceased, implying that they are currently active or their status is unknown.

Best Publications

  • 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

    Thomas J. Ryan;Elliott M. Antman;Neil H. Brooks;Robert M. Califf

  • Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review

    W D Weaver;R J Simes;A Betriu;C L Grines

  • Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction.

    Cannon Cp;Gibson Cm;Lambrew Ct;Shoultz Da

  • ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction

    Thomas J. Ryan;Jeffrey L. Anderson;Elliott M. Antman

  • Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction Results From an International Trial of 41 021 Patients

    Kerry L. Lee;Lynn H. Woodlief;Eric J. Topol;W. Douglas Weaver

  • Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.

    Karen P. Alexander;L. Kristin Newby;Christopher P. Cannon;Paul W. Armstrong

  • Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators

    J S Hochman;J E Tamis;T D Thompson;W D Weaver

  • Prehospital-Initiated vs Hospital-Initiated Thrombolytic Therapy: The Myocardial Infarction Triage and Intervention Trial

    W D Weaver;M Cerqueira;A P Hallstrom;P E Litwin

  • Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study

    Peter A McCullough;Edward F Philbin;John A Spertus;Scott Kaatz

  • Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction.

    W J Rogers;L J Bowlby;N C Chandra;W J French

  • Darapladib for preventing ischemic events in stable coronary heart disease.

    Harvey D. White;Claes Held;Ralph Stewart;Elizabeth Tarka

  • Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial

    Lars Wallentin;Robert G Wilcox;W Douglas Weaver;Håkan Emanuelsson

  • A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study

    Cindy L Grines;Donald R Westerhausen;Lorelei L Grines;J.Timothy Hanlon

  • Randomized Comparison of Coronary Thrombolysis Achieved With Double-Bolus Reteplase (Recombinant Plasminogen Activator) and Front-Loaded, Accelerated Alteplase (Recombinant Tissue Plasminogen Activator) in Patients With Acute Myocardial Infarction

    C Bode;R W Smalling;G Berg;C Burnett

  • TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction Results of the TIMI 10B Trial

    Christopher P. Cannon;C. Michael Gibson;Carolyn H. McCabe;A. A. Jennifer Adgey

  • Acute coronary care in the elderly, Part II ST-segment-elevation myocardial infarction a scientific statement for healthcare professionals from the american heart association council on clinical cardiology

    Karen P. Alexander;L. Kristin Newby;Paul W. Armstrong;Christopher P. Cannon

  • ACCF/SCAI/STS/MTS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization. Commentary

    Frederick A. Masoudi;Ralph G. Brindis;W. Douglas Weaver;Timothy J. Gardner

  • Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

    Pilote L;Califf Rm;Sapp S;Miller Dp

  • Gender Differences in the Treatment and Outcome of Acute Myocardial Infarction: Results From the Myocardial Infarction Triage and Intervention Registry

    Charles Maynard;Paul E. Litwin;Jenny S. Martin;W. Douglas Weaver

  • Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention A Platelet Inhibition and Patient Outcomes (PLATO) Trial Subgroup Analysis

    Philippe Gabriel Steg;Stefan James;Robert A. Harrington;Diego Ardissino

Frequent Co-Authors

Charles Maynard
Charles Maynard University of Washington
Robert M. Califf
Robert M. Califf Duke University
Christopher B. Granger
Christopher B. Granger Duke University
Alfred P. Hallstrom
Alfred P. Hallstrom University of Washington
Paul W. Armstrong
Paul W. Armstrong University of Alberta
Harvey D. White
Harvey D. White Auckland City Hospital
Eric J. Topol
Eric J. Topol Scripps Research Institute
Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
W. Brian Gibler
W. Brian Gibler University of Cincinnati
Judith S. Hochman
Judith S. Hochman New York University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens doors to a range of related healthcare degrees and flexible career pathways. Aspiring healthcare professionals who seek a quicker entry into the field may consider accelerated healthcare programs. These options allow students to complete their studies faster while gaining the knowledge needed for administrative roles.

For registered nurses wanting to advance their careers, specific pathways like adn to fnp programs provide a bridge from an Associate Degree in Nursing to a Family Nurse Practitioner role—all online. This creates opportunities for higher responsibility and earning potential.

Those interested in preventive care, wellness, and nutrition can pursue an online dietitian degree. This qualification prepares graduates for essential roles in hospitals, schools, and private practice.

For those aspiring to lead healthcare organizations, exploring cahme accredited online mha programs is a smart move. Earning a Master of Health Administration online ensures a rigorous, accredited education while offering the flexibility needed by working professionals.

Best Scientists Citing W. Douglas Weaver

Trending Scientists

Recently Published Articles